Hybio Pharmaceutical Co.. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -44.18% vs -22.32% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -199.60% vs 8.21% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "133.70",
          "val2": "239.50",
          "chgp": "-44.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-40.30",
          "val2": "126.50",
          "chgp": "-131.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "22.60",
          "val2": "25.30",
          "chgp": "-10.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.20",
          "chgp": "-150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-74.80",
          "val2": "75.10",
          "chgp": "-199.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-301.10%",
          "val2": "389.80%",
          "chgp": "-69.09%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 40.82% vs -39.12% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 65.06% vs -38.36% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "589.60",
          "val2": "418.70",
          "chgp": "40.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "109.70",
          "val2": "-222.80",
          "chgp": "149.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "117.90",
          "val2": "125.80",
          "chgp": "-6.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-82.40",
          "val2": "-44.50",
          "chgp": "-85.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-180.10",
          "val2": "-515.40",
          "chgp": "65.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-58.00%",
          "val2": "-902.10%",
          "chgp": "84.41%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

133.70

239.50

-44.18%

Operating Profit (PBDIT) excl Other Income

-40.30

126.50

-131.86%

Interest

22.60

25.30

-10.67%

Exceptional Items

-0.10

0.20

-150.00%

Consolidate Net Profit

-74.80

75.10

-199.60%

Operating Profit Margin (Excl OI)

-301.10%

389.80%

-69.09%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -44.18% vs -22.32% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -199.60% vs 8.21% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

589.60

418.70

40.82%

Operating Profit (PBDIT) excl Other Income

109.70

-222.80

149.24%

Interest

117.90

125.80

-6.28%

Exceptional Items

-82.40

-44.50

-85.17%

Consolidate Net Profit

-180.10

-515.40

65.06%

Operating Profit Margin (Excl OI)

-58.00%

-902.10%

84.41%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 40.82% vs -39.12% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 65.06% vs -38.36% in Dec 2023

All Annual Results